AWM
BIIB icon

Accredited Wealth Management’s Biogen BIIB Stock Holding History

Accredited Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$2.1K Buy
200
+185
+1,233% +$25K ﹤0.01% 348
2025
Q2 		$1.88K Hold
15
– – ﹤0.01% 348
2025
Q1 		$2.05K Hold
15
– – ﹤0.01% 327
2024
Q4 		$2.29K Buy
+15
New +$2.53K ﹤0.01% 322

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Accredited Wealth Management's BIIB Position: Q3 2025 in Review

Accredited Wealth Management increased its Biogen (BIIB) stake by 1,233% in Q3 2025, buying an estimated $25K and bringing the position to 200 shares worth $2.1K. The position accounts for ﹤0.01% of the portfolio, ranked #348.

Accredited Wealth Management first reported a position in BIIB in Q4 2024 and has held it in 4 quarters since. The position peaked at $2.29K in Q4 2024. 906 funds tracked by Wall St. Rank hold BIIB as of Q3 2025.

  • Accredited Wealth Management held 200 shares of Biogen worth $2.1K as of Q3 2025.
  • Accredited Wealth Management bought 185 Biogen shares in Q3 2025, an estimated $25K.
  • Biogen made up ﹤0.01% of Accredited Wealth Management's portfolio in Q3 2025, its #348 holding.
  • Accredited Wealth Management first reported a position in Biogen in Q4 2024 and has held it in 4 quarters since.
  • Accredited Wealth Management's Biogen position peaked at $2.29K in Q4 2024.
  • 906 funds tracked by Wall St. Rank held Biogen as of Q3 2025.

Based on Accredited Wealth Management's 13F filing for Q3 2025, filed 12 Nov 2025.